ESTIMATE analysis indicated that cluster 2 had a higher stromal score, immune score, estimate score, and lower tumor purity compared with cluster 1 in the different glioma cohorts and both IDH subtypes (Figures 4D–F and Supplementary Figures S1D–L). Here, IDH1 is linked to central nervous system cancer.